STING signaling: a key to therapeutic tumor immunity

Immunotherapy. 2018 Jul;10(9):729-731. doi: 10.2217/imt-2018-0064.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • B7-H1 Antigen / immunology
  • Cancer Vaccines / immunology*
  • Cell Movement
  • Humans
  • Immune Tolerance
  • Immunity, Innate
  • Immunotherapy / methods*
  • Lymphocyte Activation
  • Membrane Proteins / immunology
  • Membrane Proteins / metabolism*
  • Mice
  • Neoplasms / immunology*
  • Neoplasms / therapy
  • Programmed Cell Death 1 Receptor / immunology
  • T-Lymphocytes / immunology*
  • Tumor Microenvironment

Substances

  • Antibodies, Monoclonal
  • B7-H1 Antigen
  • Cancer Vaccines
  • Membrane Proteins
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • STING1 protein, human